Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
02/2005
02/03/2005WO2005010063A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer
02/03/2005WO2005009993A1 Novel compounds
02/03/2005WO2005009958A1 Ppar active compounds
02/03/2005WO2005009947A2 Aryl heteroaromatic products, compositions comprising the same and use thereof
02/03/2005WO2005009370A2 Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
02/03/2005WO2004074242A3 Halogenated oxime derivatives and the use thereof as latent acids
02/03/2005WO2004009083A8 Antitumor compound and therapeutic uses thereof
02/03/2005US20050027130 Rhodamine dye compounds for patterns with DNA sequences for kits
02/03/2005US20050026988 Cyclopenta'b! indole derivatives as spla inhibitors
02/03/2005US20050026976 Isoindolinone kinase inhibitors
02/03/2005US20050026975 Such as ethyl 4-chloroacetamido-N-(3,4-dichlorobenzyl)indole-2-carboxylate use in the treatment of disease mediated by monocyte chemoattractant protein-1
02/03/2005US20050026972 Benzimidazol-or indol-aminoacetonitrile derivatives for parasite control
02/03/2005US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
02/03/2005US20050026905 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
02/03/2005US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke
02/03/2005US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
02/03/2005DE19816479B4 Verfahren zur Herstellung von Enaminen, Iminen, Indolen und Diaminen aus Alkinen und deren Weiterverarbeitung durch katalytische Hydrierung Process for the preparation of enamines, imines, indoles and diamines from alkynes and their further processing by catalytic hydrogenation
02/03/2005DE10335092B3 Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung Benzoylureido substituted-o-benzoylamide, processes for their preparation and their use
02/03/2005DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases
02/03/2005CA2533494A1 Aryl heteroaromatic products, compositions comprising the same and use thereof
02/03/2005CA2532403A1 Ppar active compounds
02/03/2005CA2532248A1 Novel compounds
02/02/2005EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives
02/02/2005EP1501840A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and polymers therefrom
02/02/2005EP1501826A2 Substituted indoles as alpha-1 agonists
02/02/2005EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors
02/02/2005EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors
02/02/2005EP1501503A1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances
02/02/2005EP1501502A2 Carvedilol pharmasolve solvate
02/02/2005EP1330233B1 Method of treating stroke
02/02/2005EP1297175A4 Methods and compounds for modulating nuclear receptor coactivator binding
02/02/2005EP0828754B1 Dipeptides which promote release of growth hormone
02/02/2005CN1575170A (-)-1-(3, 4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
02/02/2005CN1573578A Electrophotographic organophotoreceptors with novel charge transport compounds
02/02/2005CN1573577A Organophotoreceptors with azine-based compounds
02/02/2005CN1572787A Method for synthesis of aspirin nitroxymethylphenyl esters and its derivatives
02/02/2005CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application
02/02/2005CN1187329C Preparation method of 3-oxyindole derivative for synthesizing indigo
02/02/2005CN1187328C Method for synthesizing indigo by using N-substituted glycine or glycine ester
02/02/2005CN1187326C Novel compounds
02/02/2005CN1187056C Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts
02/01/2005US6849713 Topisomerase inhibitor
02/01/2005US6849656 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
02/01/2005US6849641 Azaindole tyrosine kinase inhibitors
02/01/2005US6849632 Heteroaryl alkyl piperazine derivatives
02/01/2005US6849367 Photoconductive layer containing azo compound; electrostaticlatent image
01/2005
01/27/2005WO2005007621A2 Ubiquitin ligase inhibitors
01/27/2005WO2004096765A3 A novel crystalline polymorph of fluvastatin sodium and a process for preparing it
01/27/2005WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
01/27/2005US20050020858 Reacting alkynylamine with substituted sulfonyl chloride, reacting product with substituted 2-iodophenylamine compound, cyclizing product to produce indole derivatives; inhibitors of cytosolic phospholipase A2
01/27/2005US20050020684 Modulators of peroxisome proliferator activated receptors
01/27/2005US20050020664 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
01/27/2005US20050020655 Transamination of ondansetron by a Mannich reaction
01/27/2005US20050020645 Diamine derivatives
01/27/2005US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease
01/27/2005US20050020624 Dihydroindole and tetrahydroquinoline derivatives
01/27/2005US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood
01/27/2005US20050020593 Anticancer agents
01/27/2005US20050020576 Opioid antagonist; analgesics; antiinflammatory agents; side effect reduction
01/27/2005US20050020568 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics
01/27/2005US20050020508 Artificial sweenening for food, beverages
01/26/2005EP1499898A2 Regulation of tnf-alpha
01/26/2005EP1499623A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
01/26/2005EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
01/26/2005EP1499583A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
01/26/2005EP1499310A2 Carvedilol monocitrate monohydrate
01/26/2005EP1499306A2 Bicyclic amides
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1
01/26/2005CN1569834A Benzyloxy substituted indole compound and its analog and their production method and application
01/26/2005CN1569833A Indigo derivative and its preparing process and application
01/26/2005CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors
01/26/2005CN1186339C Pyrimidinyl methyl indole derivatives with antibacterial activity
01/26/2005CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity
01/25/2005US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/25/2005US6846840 Alkylating agents possessing both in vitro cytotoxicity and antitumor activity; for therapy of cancer
01/25/2005US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect
01/25/2005US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis
01/25/2005US6846832 Highly selective monoamine oxidase B inhibitors; treating Alzheimer's disease, Parkinson's disease, and senile dementia
01/25/2005US6846825 Antibacterial agents
01/25/2005US6846820 For therapy of diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
01/25/2005US6846819 Bactericides compound containing acrylamide group
01/25/2005US6846607 For increasing sensitivity of photoresist useful for microfabrication of integrated circuits utilizing deep ultraviolet rays (from excimer lasers) and x-rays; resolution; profile
01/25/2005CA2231201C Toilet bowl cleaning tablet
01/20/2005WO2005005461A2 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
01/20/2005WO2005005415A1 Indoles useful in the treatment of inflammation
01/20/2005WO2005005409A1 Method for the production of substituted 2,6-dioxopiperidine-3-yl compounds
01/20/2005WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels
01/20/2005WO2005005386A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
01/20/2005WO2005005385A1 Novel chemiluminescent compounds and their use
01/20/2005WO2004100865A3 New benzimidazole derivatives
01/20/2005WO2004099124A3 Novel bioisosteres of actinonin
01/20/2005WO2004096802A9 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES
01/20/2005US20050014954 Pyrrole synthesis
01/20/2005US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation
01/20/2005US20050014940 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines intermediates therefore, and processes for preparing such intermediates
01/20/2005US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment
01/20/2005US20050014822 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
01/20/2005US20050014803 Enzyme inhibitors
01/20/2005US20050014766 Use of n-(indolecarbonyl-)piperazine derivatives